A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors
Status:
Not yet recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
It is a Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics,
Pharmacodynamics, and Efficacy of HB0036 in Subjects with Advanced Solid Tumors